Single Dose of SRT To Treat Recurrence After Surgical Excision: An In Vitro & In Vivo Study

November 23, 2020

A new study on Superficial Radio Therapy (SRT) shows that a single dose can be used to treat recurrence of keloid scarring after surgical excision. This study was conducted on fifteen patients with 20 untreated keloids in various anatomic locations. The results proved successful outcomes of 90%+ . The full study is attached.

</p>

Share this article

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

Patient Inquiry

Patient Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.

Physician Inquiry

Physician Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.

General Inquiry

General Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.

Sensus Healthcare partners with The Pinnacle Health Group to provide reimbursement support for all customers. Please contact Pinnacle for support by phone at 866-369-9290 or email at [email protected]. Hotline consultants are available Monday through Friday from 8:30 AM to 6:00 PM EST.

Contact Us

Social